When was GATC founded?

GATC was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is GATC located?

GATC is headquartered in Irvine, United States.

How many employees does GATC have?

As of May 31, 2026, the latest employee count at GATC is 51.

Is GATC a funded company?

GATC is a funded company, having raised a total of $38.3M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 01, 2021.

When was the latest funding round of GATC?

GATC's latest funding was a $***** Series B round on Apr 12, 2023, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $2.56B in funding in 2026 to date.

Where does GATC rank among its competitors?

GATC ranks 6th amongst 133 active competitors, of which 39 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was IMU Biosciences, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of GATC?

GATC's top competitors include Cellworks, Life Bit and IMU Biosciences. Among them, IMU Biosciences secured the most recent funding round in June, 2026.

GATC - 2026 Company Profile, Funding & Competitors

Company Details

AI-based omic data analysis platform for researchers and professionals. The company has devised a personalized medical omic analysis platform MAT that assists with predictive multi-omic datasets. The platform developed by the company supports biological data sets for pathway analysis, dataset evaluation, and more. The AI technology used in the software assists with biological pathway analysis for disease pathology, drug discovery, and other therapeutic solutions.

Website: gatchealth.com
Email ID: *****@gatchealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2020

Location

Irvine, United States

Stage

Series B

Total Funding

$38.3M in 3 rounds

Latest Funding Round

Series B, Apr 12, 2023, $*****

Ranked

6^th among 133 active competitors

Employee Count

51 as on May 31, 2026

Similar Companies

Cellworks & 153 more

View GATC's full profile

GATC is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GATC HEALTH CORP CIN: 851074632 , United States, Active	Dec 31, 2019	$1 - $1M (As on Sep 19, 2023)	-	-

GATC has raised a total funding of $38.3M over 3 rounds. Its first funding round was on Sep 01, 2021.

Here is the list of recent funding rounds of GATC:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 12, 2023	9417214	Series B	8999828	5022720	8264881	4756256
Dec 21, 2021	6365751	Series A	5239481	3674610	9736623	6379594
Sep 01, 2021	8821274	Seed	4793623	8497524	6628382	2906632

Access funding benchmarks and valuations. Sign up today!

View details of GATC's funding rounds and investors

GATC's employee count trend

GATC has 51 employees as of May 26. Here is GATC's employee count trend over the years:

Uncover GATC's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GATC include Cellworks, Life Bit and IMU Biosciences. Here is the list of Top 10 competitors of GATC, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 3 others	65/100
2nd	Life Bit 2017, London (United Kingdom), Series B	AI and SaaS-based genomics analysis software for drug development	$70.9M	Tiger Global Management, Connect Ventures ... & 13 others	56/100
3rd	IMU Biosciences 2019, London (United Kingdom), Series A	Provider of immune discovery platform for precision medicines	$53M	Molten Ventures, IQ Capital & 4 others	56/100
4th	ICarbonX 2015, Shenzhen (China), Series D	Provider of bioinformatic platforms for health management and drug development	$366M	Wealthking Investments, China Investment Corporation ... & 11 others	55/100
5th	Biostate 2023, Houston (United States), Series A	Developer of generative AI based RNAstate research platform to predict future omics states	$16M	Accel, Catapult & 10 others	54/100
6th	GATC 2020, Irvine (United States), Series B	AI-based omic data analysis platform for researchers and professionals	$38.3M	-	54/100
7th	Codetta 2021, Morrisville (United States), Series A	Online platform for analyzing omics clinical data	$27.3M	Anzu Partners, VC23 & 2 others	53/100
8th	NeoCura 2017, Changping (China), Series A	Provider of an AI-enabled immunotherapy based tumor diagnostic platform	$38.2M	CDH, PICC Capital Investment Management & 5 others	52/100
9th	Liquid Biosciences 2017, Aliso Viejo (United States), Series C	Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes	$40.1M	-	51/100
10th	Watershed 2019, Sacramento (United States), Series A	Provider of software solution for biological data analysis, discovery, and collaboration	$19.7M	Canvas Ventures, Bessemer Venture Partners ... & 3 others	48/100